Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Interleukin-33 Contributes Toward Loss of Tolerance by Promoting B-Cell-Activating Factor of the Tumor-Necrosis-Factor Family (BAFF)-Dependent Autoantibody Production.

Rose WA 2nd, Okragly AJ, Hu NN, Daniels MR, Martin AP, Koh YT, Kikly K, Benschop RJ.

Front Immunol. 2018 Dec 6;9:2871. doi: 10.3389/fimmu.2018.02871. eCollection 2018.

2.

Human mast cells release the migraine-inducing factor pituitary adenylate cyclase-activating polypeptide (PACAP).

Okragly AJ, Morin SM, DeRosa D, Martin AP, Johnson KW, Johnson MP, Benschop RJ.

Cephalalgia. 2018 Aug;38(9):1564-1574. doi: 10.1177/0333102417740563. Epub 2017 Nov 5.

PMID:
29103295
3.

Elevated levels of Interleukin (IL)-33 induce bone pathology but absence of IL-33 does not negatively impact normal bone homeostasis.

Okragly AJ, Hamang MJ, Pena EA, Baker HE, Bullock HA, Lucchesi J, Martin AP, Ma YL, Benschop RJ.

Cytokine. 2016 Mar;79:66-73. doi: 10.1016/j.cyto.2015.12.011. Epub 2016 Jan 6.

PMID:
26771472
4.

IL-33 released by alum is responsible for early cytokine production and has adjuvant properties.

Rose WA 2nd, Okragly AJ, Patel CN, Benschop RJ.

Sci Rep. 2015 Aug 14;5:13146. doi: 10.1038/srep13146.

5.

LIGHT-deficiency impairs CD8+ T cell expansion, but not effector function.

Liu J, Schmidt CS, Zhao F, Okragly AJ, Glasebrook A, Fox N, Galbreath E, Zhang Q, Song HY, Na S, Yang DD.

Int Immunol. 2003 Jul;15(7):861-70.

PMID:
12807825
6.

A p74 common gamma receptor chain isoform facilitates IL-2 and IL-15 responses by the myelomonocytic cell line Tf-1beta2.

Monson NL, Fenske TJ, Wei S, Okragly AJ, de Jong JL, Haak-Frendscho M, O'Shea J, Djeu J, Sondel PM.

J Leukoc Biol. 2001 Mar;69(3):419-25.

PMID:
11261789
7.

Cervical dorsal rhizotomy increases brain-derived neurotrophic factor and neurotrophin-3 expression in the ventral spinal cord.

Johnson RA, Okragly AJ, Haak-Frendscho M, Mitchell GS.

J Neurosci. 2000 May 15;20(10):RC77.

8.

Facile generation and use of immunogenic polypeptide fusions to a sparingly soluble non-antigenic protein carrier.

Knuth MW, Okragly AJ, Lesley SA, Haak-Frendscho M.

J Immunol Methods. 2000 Mar 6;236(1-2):53-69.

PMID:
10699579
9.

Elevated tryptase, nerve growth factor, neurotrophin-3 and glial cell line-derived neurotrophic factor levels in the urine of interstitial cystitis and bladder cancer patients.

Okragly AJ, Niles AL, Saban R, Schmidt D, Hoffman RL, Warner TF, Moon TD, Uehling DT, Haak-Frendscho M.

J Urol. 1999 Feb;161(2):438-41; discussion 441-2. Erratum in: J Urol 1999 Jun;161(6):1915.

PMID:
9915421
10.

GDNF is abundant in the adult rat gut.

Peters RJ, Osinski MA, Hongo JA, Bennett GL, Okragly AJ, Haak-Frendscho M, Epstein ML.

J Auton Nerv Syst. 1998 May 28;70(1-2):115-22.

PMID:
9686911
11.

An acid-treatment method for the enhanced detection of GDNF in biological samples.

Okragly AJ, Haak-Frendscho M.

Exp Neurol. 1997 Jun;145(2 Pt 1):592-6.

PMID:
9217096
12.

Autologous mixed leucocyte reaction and the polyclonal activation of bovine gamma/delta T cells.

Hanby-Flarida MD, Okragly AJ, Baldwin CL.

Res Vet Sci. 1996 Jul;61(1):65-71.

PMID:
8819197
13.
14.

Monocytes control gamma/delta T-cell responses by a secreted product.

Okragly AJ, Hanby-Flarida M, Baldwin CL.

Immunology. 1995 Dec;86(4):599-605.

Supplemental Content

Loading ...
Support Center